Works matching IS 02724391 AND DT 2007 AND VI 68 AND IP 6

Results: 16

Antiepileptic drugs in the preventive treatment of migraine in children and adolescents.

Published in:

Drug Development Research, 2007, v. 68, n. 6, p. 355, doi. 10.1002/ddr.20201

By:

Vollono, Catello;
Ferraro, Diana;
Valeriani, Massimiliano

Publication type:

Article

Melatonin therapy for headache disorders.

Published in:

Drug Development Research, 2007, v. 68, n. 6, p. 329, doi. 10.1002/ddr.20196

By:

Peres, Mario F.P.;
Masruha, Marcelo Rodrigues;
Rapoport, Alan M.

Publication type:

Article

Triptan efficacy in migraine attacks: from appropriate diagnosis to metabolic profiles and pharmacogenomics.

Published in:

Drug Development Research, 2007, v. 68, n. 6, p. 335, doi. 10.1002/ddr.20197

By:

Buzzi, M. Gabriella

Publication type:

Article

Preventive therapies of pediatric migraine.

Published in:

Drug Development Research, 2007, v. 68, n. 6, p. 350, doi. 10.1002/ddr.20200

By:

Pakalnis, Ann

Publication type:

Article

Looking in the wrong place? The search for an ideal migraine preventative.

Published in:

Drug Development Research, 2007, v. 68, n. 6, p. 376, doi. 10.1002/ddr.20204

By:

Lambert, Geoffrey A.

Publication type:

Article

Migraine genetics and prospects for pharmacotherapy.

Published in:

Drug Development Research, 2007, v. 68, n. 6, p. 282, doi. 10.1002/ddr.20192

By:

Colson, N.J.;
Fernandez, F.;
Griffiths, L.R.

Publication type:

Article

Role of neuropeptides in migraine: where do they stand in the latest expert recommendations in migraine treatment?

Published in:

Drug Development Research, 2007, v. 68, n. 6, p. 294, doi. 10.1002/ddr.20193

By:

Samsam, M.;
Coveñas, R.;
Ahangari, R.;
Yajeya, J.;
Narváez, J.A.

Publication type:

Article

Prioritizing migraine biomarkers research.

Published in:

Drug Development Research, 2007, v. 68, n. 6, p. 267, doi. 10.1002/ddr.20189

By:

Gurwitz, David;
Diamond, Seymour

Publication type:

Article

Effects of antiepileptic drugs on neurophysiologic abnormalities subtending migraine.

Published in:

Drug Development Research, 2007, v. 68, n. 6, p. 369, doi. 10.1002/ddr.20203

By:

de Tommaso, Marina

Publication type:

Article

Role of NSAIDs in acute treatment of headache.

Published in:

Drug Development Research, 2007, v. 68, n. 6, p. 276, doi. 10.1002/ddr.20191

By:

Martelletti, Paolo;
Farinelli, Ivano;
Coloprisco, Gabriella;
Patacchioli, Francesca Romana

Publication type:

Article

Peripheral sensitization in migraine-role for P2X purinergic receptors in the dura-vascular sensory pathway.

Published in:

Drug Development Research, 2007, v. 68, n. 6, p. 321, doi. 10.1002/ddr.20195

By:

Jennings, Ernest A.;
Cho, Hyun-jung

Publication type:

Article

Triptans in children and adolescents.

Published in:

Drug Development Research, 2007, v. 68, n. 6, p. 346, doi. 10.1002/ddr.20199

By:

Gladstein, Jack

Publication type:

Article

Dopamine antagonists and migraine.

Published in:

Drug Development Research, 2007, v. 68, n. 6, p. 341, doi. 10.1002/ddr.20198

By:

McGeeney, Brian E.

Publication type:

Article

Treatment of migraine in the emergency department.

Published in:

Drug Development Research, 2007, v. 68, n. 6, p. 360, doi. 10.1002/ddr.20202

By:

Hunter, Gary;
Téllez-Zenteno, José F.

Publication type:

Article

Evolution of migraine drugs.

Published in:

Drug Development Research, 2007, v. 68, n. 6, p. 270, doi. 10.1002/ddr.20190

By:

Diamond, Seymour

Publication type:

Article

Newer aspects of migraine preventive therapies.

Published in:

Drug Development Research, 2007, v. 68, n. 6, p. 315, doi. 10.1002/ddr.20194

By:

Freitag, Frederick G.

Publication type:

Article